Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Experimental and Therapeutic Medicine

Volumn 5, Issue 4, 2013, Pages 1206-1210

  Ma, Yi ^a   Li, Li ^a   Shang, Xiao Ming ^a   Tan, Zheng ^a   Geng, Xue Bin ^a   Zhao, Bi Qiong ^a   Tian, Mei Rong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Myocardial infarction; Percutaneous coronary intervention; Risk factors; Short term prognosis

Indexed keywords

CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; GLUCOSE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; ISOENZYME ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR;

EID: 84874636816     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.927     Document Type: Article

References (24)

1. Ruiz-Bailén M, Aguayo de Hoyos E, Ramos-Cuadra JA, et al:Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population. Int J Cardiol 85: 285-296, 2002.
2. Polewczyk A, Janion M, Gasior M, et al: Benefits from revascularisation therapy in the elderly with acute myocardial infarction. Comparative analysis of patients hospitalised in 1992-1996 and in 2005-2006. Kardiol Pol 68: 873-881, 2010.
3. De Luca G, Suryapranata H, Dambrink JH, et al: Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. Am Heart J 148: 852-856, 2004.
4. Griffith D, Hamilton K, Norrie J and Isles C: Early and late mortality after myocardial infarction in men and women: prospective observational study. Heart 91: 305-307, 2005.
5. Bickel C, Rupprecht HJ, Blankenberg S, et al:: Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89: 12-17, 2002.
6. Short RA, Johnson RT and Tuttle KR: Uric acid, microalbuminuria and cardiovasular events in high-risk patients. Am J Nephrol 25: 36-64, 2005.
7. Car S and Trkulja V: Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. Croat Med J 50: 559-566, 2009.
8. Washio T, Nomoto K, Watanabe I, et al: Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failure. Int Heart J 52: 224-228, 2011.
9. Kadri Z, Danchin N, Vaur L, et al:; Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 92: 910-915, 2006.
10. Coyal A, Mehta SR, Gerstein HC, et al: Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J 157: 763-770, 2009.
11. Ishihara M, Kojima S, Sakomoto T, et al; Comparison of blood glucose value on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol 104: 769-774, 2009.
12. Wahab NN, Cowden EA, Pearce NJ, et al: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40: 1748-1754, 2002.
13. Ceriello A: Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 26: 328-331, 2005.
14. Norhamraar A, Tenerz A, Nilsson G, et al: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes meullitus: a prospective study. Lancet 359: 2140-2l44, 2002.
15. Yan MZ, Hu Dy, Yu JM, et al: Newly diagnosed abnormal glucose tolerance in patients with acute coronary syndrome and without known diabetes mellitus. Zhonghua Yi Xue Za Zhi 86: 1256-1259, 2006 (In Chinese).
16. Gore JM, Goldberg RJ, Matsumoto AS, et al: Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 54: 722-725, 1984.
17. Fyfe T, Baxter RH, Cochran KM, et al: Plasma-lipid changes after myocardial infarction. Lancet 2: 997-1001, 1971.
18. Kitsis RN and Jialal I: Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N Engl J Med 355: 513-515, 2006.
19. Gharacholou SM, Lopes RD, Alexander KP, et al: Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial. Arch Intern Med 171: 559-567, 2011.
20. Kala P, Kanovsky J, Rokyta R, et al: Age-related treatment strategy and long-term outcome in acute myocardial infarction patients in the PCI era. BMC Cardiovasc Disord 12: 31, 2012.
21. Tuomainen PO, Ylitalo A, Niemelä M, et al: Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial. J Invasive Cardiol 24: 104-108, 2012.
22. Li Z, Li ZZ, Gao YL, et al: On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies. Zhonghua Xin Xue Guan Bing Za Zhi 40: 225-230, 2012 (In Chinese).
23. Bae MH, Lee JH, Lee SH, et al: Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. Circ J 75: 1440-1447, 2011.
24. Kim SY, Guevara JP, Kim KM, et al: Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62: 170-180, 2010.